Real-world estimates suggest approximately 50% of GLP-1 users experience some form of localized reaction during their treatment course
Resources We Trust Cleveland Clinic: Bariatric Surgery American Society for Metabolic and Bariatric Surgery: For Patients Obesity Alliance Coalition: Weight-Loss Surgery and Fitness The Dos and Donts for a Successful Exercise Program American College of Surgeons: The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Surgical Risk/Benefit Calculator StatPearls: Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me
Novelty The established literature widely acknowledges GHK-Cus regenerative capacity in skin and systemic wound healing
Sujan AC, Rickert ME, berg AS, Quinn PD, Hernndez-Daz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM
It was designed to treat obesity by targeting peripheral receptors, but some researchers believe it might actually exert its effects through CB1 receptors in the central nervous system 15